Categories: Web and IT News

Resverlogix Announces Updated Annual and Special Meeting of Shareholders

Resverlogix Announces Updated Annual and Special Meeting of Shareholders


Calgary, Alberta–(Newsfile Corp. – May 28, 2024) – Resverlogix Corp. (TSX: RVX) (“Resverlogix” or the “Company”) announced today that its Annual and Special Meeting of Shareholders (the “Meeting”) will be held on Wednesday, July 31, 2024, commencing at approximately 1:00 pm (MT), as opposed to as previously scheduled for June 27, 2024.

A Notice of Meeting and Management Information Circular, containing the matters to be considered at the Meeting, will be delivered to shareholders and filed on SEDAR+ at www.sedarplus.ca.

Following the formal business of the Meeting, a corporate update presentation will be provided.

About Resverlogix

Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease.

Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.

The Company’s clinical program is focused on evaluating the lead epigenetic candidate apabetalone for the treatment of cardiovascular disease, associated comorbidities, and post COVID-19 conditions.

Resverlogix has partnered with EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, to support the rapid commercialization of apabetalone for cardiovascular disease, post COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

Resverlogix common shares trade on the Toronto Stock Exchange (TSX: RVX).

Follow us on:

Forward-Looking Statements:

This news release may contain certain forward-looking information as defined under applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts”, and other similar expressions. In particular, this news release includes forward looking information related to the upcoming Annual and Special Meeting of Shareholders and the potential role of apabetalone in the treatment of patients with cardiovascular disease, post COVID-19 conditions, pulmonary arterial hypertension, associated comorbidities, and other chronic diseases. Our actual results, events or developments could be materially different from those expressed or implied by these forward-looking statements. We can give no assurance that any of the events or expectations will occur or be realized. By their nature, forward-looking statements are subject to numerous assumptions and risk factors including those discussed in our Annual Information Form and most recent MD&A which are incorporated herein by reference and are available through SEDAR+ at www.sedarplus.ca. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information please contact:

Investor Relations
Email: ir@resverlogix.com
Phone: 403-254-9252
Or visit our website: www.resverlogix.com

The post Resverlogix Announces Updated Annual and Special Meeting of Shareholders first appeared on PressRelease.cc.

Resverlogix Announces Updated Annual and Special Meeting of Shareholders first appeared on Web and IT News.

awnewsor

Recent Posts

Swipekit’s 2026 Meta Ad Creative Benchmarks gathers data from 13,995 Meta ads

The report analyzed 13,995 Meta ads from 592 tracked brands. The median run time was…

3 hours ago

ConConAI Announces Expansion of Its AI-Powered Commerce Ecosystem Following $CON Token Launch

ConConAI, an AI-powered personal purchase advisor platform, has announced the next stage of its ecosystem…

3 hours ago

Brandlight Launches New Tools to Help Enterprises Prepare for OpenAI’s Businesses in ChatGPT

New capabilities help enterprises configure ChatGPT Business Agents and prepare product catalogs, as Brandlight emphasizes…

3 hours ago

OrdoAI Expands into AI Products, Drawing on Its Global Marketing Experience

Its first AI agent product, Ordo Brand, is in invitation-only private beta, with a public…

6 hours ago

FBI Warns ARTEX AI Agents Are Compressing Cyberattacks Into Hours

The FBI wants companies to look hardest at the systems they watch least. In a…

6 hours ago

Firmus Wants Its Biggest Customers to Pay Up Front for AI Data Centers It Hasn’t Built

Five weeks after it scrapped what would have been Australia’s biggest stock market debut since…

6 hours ago

This website uses cookies.